Moreover, our transcriptome results provided insights into the key factors associated with unresponsive anti-PD-1/PD-L1 treatment in OC, but our study was limited by a small sample size and the absence of tumor samples from anti-PD-1 responsive mice. This evidence concerns the gene CD274 and neoplasm.